Credit Suisse Ag Essa Pharma Inc. Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.15 - $7.94 $70,263 - $177,109	-22,306 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.18 - $14.44 $61,385 - $143,432	9,933 Added 80.28%	22,306 $139,000
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $10,452 - $19,269	-1,340 Reduced 9.77%	12,373 $176,000
Q3 2021 Nov 12, 2021	BUY	$7.76 - $29.37 $11,539 - $43,673	1,487 Added 12.16%	13,713 $110,000
Q2 2021 Aug 16, 2021	BUY	$24.17 - $34.28 $295,502 - $419,107	12,226 New	12,226 $348,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $71.8M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.